Hear four experts from ICON and Kap Code provide insights on how to collect, use, analyze, and interpret social media data in different contexts.

Many new data are emerging in recent years – real time data is collected through digital health technologies, including apps and wearables, monitoring data, social media data, public datasets, and patient organization data, in addition to primary and secondary datasets.

Real life data are highly informative and can be used to address a range of challenges throughout the product life cycle. Data from social media can generate valuable insights as patients often gather in digital communities to get answers and share their experiences. Conversations on social networks merit special consideration as they can have real world influence over treatment management decisions.

Social media data can reveal the motivations that impact patient healthcare decisions and behaviors through each stage of the care pathway. These data provide both the patient and caregiver perspectives at the same time. For this reason, conversations on social networks offer an opportunity to deepen our understanding on:

  • The fears and hopes associated with patient treatments
  • Daily needs and difficulties patients are facing in managing their disease
  • The impact of disease on patient health related quality of life
  • Identification in real life of the stages of the care pathway and patient perceptions
  • Reactions to health policies

These experts share knowledge from over fifteen years of successfully developing and adapting algorithms to treat this kind of data.

Key Topics Include:

  • The why, when, what and how of social media data use
  • Different types of successful projects using this data
  • How to think critically about its use
  • The do’s and don’ts on communicating social media data results

Who Should Attend?

This webinar will be particularly useful for cross-functional teams engaged in clinical research, including executives, directors and project leaders from pharma and biotech involved in clinical research conduct. Specific roles include:

  • Research and development
  • Clinical operations
  • Clinical science
  • Outcomes researchers
  • Medical affairs
  • Marketing
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.


To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.


Senior Principal
Patient Centred Outcomes
ICON plc

Elodie de Bock combines more than 15 years’ experience in life sciences and health research, with significant expertise in the analysis of clinical outcomes assessments (COA) data. At ICON, she leads the Patient Centred Outcomes (PCO) Quantitative Centre of Excellence.

Research Associate
Patient Centred Outcomes
ICON plc

Valentin Barbier joined the Patient Centred Outcomes (PCO) team at ICON in 2019. His role involves performing analyses of clinical outcomes assessments (COA) data from clinical and epidemiological studies, with significant expertise in Natural Language Processing that he applies to extract information from qualitative patient interviews.

General Manager and Co-founder
Health Technology
Kap Code

Adel Mebarki has both technical and managerial skills acquired through his engineering and business school degrees. Adel has more than 9 years of experience in projects related to Big Data and artificial intelligence. His work has made him a recognized expert in the world of digital health.

International Project Manager
Health Technology
Kap Code

Joelle Malaab holds two master’s degrees: a master in Nutrition & Food Science from the University of Reading (UK) and most recently, a Master of Public Health from the Ecole des Hautes Etudes en Santé Publique in Paris, France. Her concentration revolved around management, health policies, and social and behavioral sciences.

Production Partner


ICON is a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients - reducing time to market, reducing cost and increasing quality.

Additional Content From ICON

Additional Content From HealthEconomics.Com

Related Content